Journal
EUROPEAN HEART JOURNAL
Volume 33, Issue 19, Pages 2399-+Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehs223
Keywords
Aortic stenosis; TAVI; TAVR
Categories
Funding
- Edwards Lifesciences
- St Jude Medical
Ask authors/readers for more resources
Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available